Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties
Ribosome-inactivating proteins (RIPs) are N-glycosidases, which depurinate a specific adenine residue in the conserved α-sarcin/ricin loop (α-SRL) of rRNA. This loop is important for anchoring elongation factor (EF-G for prokaryote or eEF2 for eukaryote) in mRNA translocation. Tran...
Main Authors: | Jia-Qi Lu, Zhen-Ning Zhu, Yong-Tang Zheng, Pang-Chui Shaw |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/12/3/167 |
Similar Items
-
The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations
by: Aleksander Rust, et al.
Published: (2017-10-01) -
Maize ribosome-inactivating protein as an HIV-specific cytotoxin.
Published: (2010) -
Use of Ribosome-Inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy
by: Pilar Jiménez, et al.
Published: (2011-04-01) -
Application and engineering of ribosome-inactivating proteins for targeting immunodeficiency virus
Published: (2014) -
Structures and Ribosomal Interaction of Ribosome-Inactivating Proteins
by: Wei-Wei Shi, et al.
Published: (2016-11-01)